ThisCART19A is under clinical development by Suzhou Fundamenta Therapeutics and currently in Phase I for Acquired (Autoimmune) Hemolytic Anemia.
Does the ‘4% Rule’ Make Sense for Doctors?
The “4% rule” is nearly universal in the personal finance space. My goal here is to explain the 4% rule and its origins, while also